Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Net Sales
1,513.39
1,361.36
Other Operating Income
0.00
0.00
Total Operating income
1,513.39
1,361.36
Raw Material Cost
548.39
647.06
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
48.44
-79.99
Employee Cost
210.23
200.72
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
139.74
117.93
Total Expenditure (Excl Depreciation)
946.80
885.72
Operating Profit (PBDIT) excl Other Income
566.59
475.64
Other Income
104.57
71.67
Operating Profit (PBDIT)
671.16
547.31
Interest
4.99
9.81
Exceptional Items
-25.37
0.00
Gross Profit (PBDT)
640.80
537.50
Depreciation
94.48
58.95
Profit Before Tax
546.32
478.56
Tax
144.29
109.92
Provisions and contingencies
0.00
0.00
Profit After Tax
402.04
368.64
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
402.04
368.64
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
402.04
368.64
Equity Capital
112.32
111.82
Face Value
2.0
2.0
Reserves
0.00
0.00
Diluted Earnings per share
1.64
2.21
Operating Profit Margin (Excl OI)
37.44%
34.94%
Gross Profit Margin
42.34%
39.48%
PAT Margin
26.57%
27.08%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 10.66%
Standalone Net Profit
YoY Growth in nine months ended Dec 2025 is 19.62%
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 18.99%
Interest
YoY Growth in nine months ended Dec 2025 is -28.90%
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Anthem Bioscienc With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
1,513.39
4,031.22
-2,517.83
-62.46%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,513.39
4,031.22
-2,517.83
-62.46%
Raw Material Cost
548.39
659.75
-111.36
-16.88%
Purchase of Finished goods
0.00
158.44
-158.44
-100.00%
(Increase) / Decrease In Stocks
48.44
60.76
-12.32
-20.28%
Employee Cost
210.23
950.43
-740.20
-77.88%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
139.74
1,140.42
-1,000.68
-87.75%
Total Expenditure (Excl Depreciation)
946.80
2,969.80
-2,023.00
-68.12%
Operating Profit (PBDIT) excl Other Income
566.59
1,061.42
-494.83
-46.62%
Other Income
104.57
110.64
-6.07
-5.49%
Operating Profit (PBDIT)
671.16
1,172.06
-500.90
-42.74%
Interest
4.99
13.75
-8.76
-63.71%
Exceptional Items
-25.37
0.00
-25.37
Gross Profit (PBDT)
640.80
1,158.31
-517.51
-44.68%
Depreciation
94.48
127.77
-33.29
-26.05%
Profit Before Tax
546.32
1,030.54
-484.22
-46.99%
Tax
144.29
241.24
-96.95
-40.19%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
402.04
789.30
-387.26
-49.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
402.04
789.30
-387.26
-49.06%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
402.04
789.30
-387.26
-49.06%
Equity Capital
112.32
25.07
87.25
348.03%
Face Value
2.00
2.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
42.34%
28.73%
0.00
13.61%
PAT Margin
26.57%
19.58%
0.00
6.99%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,506.82 Cr
in Dec 2025Figures in Cr
Nine Monthly - Standalone Net Profit
Standalone Net Profit 458.89 Cr
in Dec 2025Figures in Cr
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 584.13 Cr
in Dec 2025Figures in Cr
Nine Monthly - Interest
Interest 4.97 Cr
in Dec 2025Figures in Cr
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 38.77%
in Dec 2025Figures in %
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
